Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc. 1:15-cv-00114; Filed:
01/30/2015; Case Updated Daily; Latest Docket Entry: 09/06/2016; PACER.
Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al. 1:15-cv-00464;
Filed: 06/05/2015; Case Updated Daily; Latest Docket Entry: 08/29/2016; PACER
... et al v. NEW JERSEY MOTOR VEHICLE COMMISSION et al ... PRISON
HEALTH SERVICES CORRECTION HEALTHCARE, INC. et al ... -MAH PECK v.
.... BAYER HEALTHCARE, LLC .... ASTRAZENECA PHARMACEUTICALS LP et
T-11-13, BAYER INC. ET AL v. MYLAN PHARMACEUTICALS ULC ET AL, S.
18.1 ... ET AL. v. VW MANUFACTURING LTD. Patent Infringement, 2013-01-09
..... T-396-13, HOSPIRA HEALTHCARE CORPORATION v. .... ET AL, Trade Mark
Infringement, 2013-04-16, Roddick & Peck & Johnson; YESDRESYSKI,
T-365-14, NOVARTIS PHARMACEUTICALS CANADA INC. v. MYLAN ...
HOSPIRA HEALTHCARE CORPORATION ET AL. ... DAVID O. SAVILLE-PECK
ET AL, Trade Mark Infringement, 2014-02-13, Gowling Lafleur ... ET AL v.
4155653 CANADA INC. ET AL, Trade Mark Infringement, 2014-03-05 ..... T-1092-
14, BAYER INC.
dents, Microsoft Corp. v. i4i Ltd. P'ship, 131 S. Ct. 2238 (2011) (No. 10-290); Brief
of ... their innovation platforms, such as those in the pharmaceutical field, seek to
fortify .... See, e.g., Brief in Opposition of Respondents Barr Labs., Inc. et al., Ark.
Carpenters .... Bayer AG (In re Ciprofloxacin Hydrochloride Anti- trust L...
U.S. v. AIG Trading Corp.; BP Exploration & Oil, Inc.; and Cargill International,
S.A. .... Arizona Hospital and Healthcare Association and AzHHA Service Corp.
Arkansas Carpenters Health and Welfare Fund, et al. and Sol Lubin, et al. v. ... v.
Bayer AG [07/14/2004] ..... v. Fujisawa Pharmaceutical Co., Ltd., and Akira Nakao
Hannah Peck a/k/a Hannah Finley, et al., from Pulaski County Circuit Court. .....
CV-14-400 and CV-14-402 Entergy Arkansas, Inc., et al. v. ... Takeda
Pharmaceuticals North America et al., an original action from the U.S. District
Court, Western ..... 12-88 Bryant Healthcare Center et al., and AR Foundation for
Medical Care v.
Dec 15, 2015 ... <sup>h</sup>FibroGen, Inc, San Francisco, Calif., USA ... Incidences of grade ≥3 drug-
related AEs were 30%, 17%, and 16% in ..... designed, and executed by Bayer
HealthCare Pharmaceuticals and ... Sansonno D, Lauletta G, Russi S, Conteduca
V, Sansonno L, ... Raoul JL, Lee HC, Kudo M, Nakajima K, Cheng AL.
A number of agents have been developed and AMG 102 (Amgen Inc) is currently
.... Sorafenib (Nexavar®, Bayer Healthcare Pharmaceuticals) is a potent Raf1 ....
high incidence of significant toxicities, the study was terminated early [Peck et al.
.... Heist, R., Papadimitrakopoulou, V., Camidge, D., Beck, J.T., Schmid, P. et al.